Literature DB >> 33074393

Efficacy of high intensity laser therapy in knee osteoarthritis: a double-blind controlled randomized study.

Mazlum Serdar Akaltun1, Ozlem Altindag2, Neytullah Turan2, Savas Gursoy2, Ali Gur2.   

Abstract

OBJECTIVE: The aim of this study is to investigate the effectiveness of high intensity laser therapy on pain, functionality, flexion range of motion (FROM), and ultrasonographic cartilage measurement in patients with knee osteoarthritis.
METHODS: This study was designed as a double-blind randomized placebo-controlled study. Forty patients diagnosed with knee osteoarthritis according to the American College of Rheumatology criteria were included in the study. After obtaining written informed consent, patients were randomized into high intensity laser therapy (HILT) + exercise therapy (ET), and placebo laser (PL) + ET groups. Each patient was treated five sessions per week for 2 weeks. The outcomes measured were pain level and functional disability using the visual analog scale (VAS) and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), respectively. The femoral cartilage thickness measurement was made ultrasonographically, and FROM was measured with goniometry.
RESULTS: Statistically significant improvements were detected in VAS, WOMAC scores, femoral cartilage thickness, and FROM at the end of the treatment (in week 2) compared to the pre-treatment period in both groups (p < 0.05). There were significant decreases in the VAS and WOMAC scores of both groups in the 6th week compared to the pre-treatment period, and the results of the FROM and femur cartilage thickness measurements were increased at statistically significant levels (p < 0.05). The VAS and WOMAC scores were significantly lower in the 6th week in HILT + ET group compared to the PL + ET group (p < 0.05). Similarly, statistically significant increases were detected in the FROM and femur cartilage thickness measurements in HILT + ET group (p < 0.05).
CONCLUSION: HILT + ET combination was more effective in KOA than the PL + ET combination. Key Points • HILT is an effective modality on pain, functional status and FROM in patients with KOA. • HILT is a modality that increases femoral cartilage thickness in patients with KOA.

Entities:  

Keywords:  Exercise; Femoral cartilage thickness; Knee osteoarthritis; Laser therapy

Mesh:

Year:  2020        PMID: 33074393     DOI: 10.1007/s10067-020-05469-7

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  2 in total

Review 1.  Knee osteoarthritis prevalence, risk factors, pathogenesis and features: Part I.

Authors:  Behzad Heidari
Journal:  Caspian J Intern Med       Date:  2011

2.  [Physical agents for pain management in patients with gonarthrosis].

Authors:  Przemysław Lisiński; Wiesław Zapalski; Wanda Stryła
Journal:  Ortop Traumatol Rehabil       Date:  2005-06-30
  2 in total
  4 in total

Review 1.  Utilization of the 1064 nm Wavelength in Photobiomodulation: A Systematic Review and Meta-Analysis.

Authors:  William Todd Penberthy; Charles E Vorwaller
Journal:  J Lasers Med Sci       Date:  2021-12-28

Review 2.  Adjunctive therapies in addition to land-based exercise therapy for osteoarthritis of the hip or knee.

Authors:  Helen P French; J Haxby Abbott; Rose Galvin
Journal:  Cochrane Database Syst Rev       Date:  2022-10-17

Review 3.  Functionalized Hydrogels for Cartilage Repair: The Value of Secretome-Instructive Signaling.

Authors:  María Julia Barisón; Rodrigo Nogoceke; Raphaella Josino; Cintia Delai da Silva Horinouchi; Bruna Hilzendeger Marcon; Alejandro Correa; Marco Augusto Stimamiglio; Anny Waloski Robert
Journal:  Int J Mol Sci       Date:  2022-05-27       Impact factor: 6.208

4.  Is high intensity laser therapy more effective than other physical therapy modalities for treating knee osteoarthritis? A systematic review and network meta-analysis.

Authors:  Menglai Wu; Lijiang Luan; Adrian Pranata; Jeremy Witchalls; Roger Adams; Jaquelin Bousie; Jia Han
Journal:  Front Med (Lausanne)       Date:  2022-09-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.